Walnut Creek, CANCT07867080Now EnrollingIRB Ready

Diabetic Macular Edema (DME) Clinical Trial in Walnut Creek, CA

Access cutting-edge diabetic macular edema (dme) treatment through this phase 3 clinical trial at a research site in Walnut Creek. Study-provided care at no cost to qualified participants.

Sponsored by 4D Molecular Therapeutics

Quick Self-Assessment

See if you qualify for this Walnut Creek location

Preparing your pre-screening questions…

Expert Care in Walnut Creek

Access diabetic macular edema (dme) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related diabetic macular edema (dme) treatment provided free

Apply for This Walnut Creek Location

Check if you qualify for this diabetic macular edema (dme) clinical trial in Walnut Creek, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Walnut Creek

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Walnut Creek site if eligible
  4. 4Begin participation

About This Diabetic Macular Edema (DME) Study in Walnut Creek

A Phase 3, Randomized, Double-Masked, Active-Controlled Trial to Evaluate the Safety, Efficacy, and Durability of a Single Intravitreal Injection of 4D-150 versus Aflibercept in Adults with Diabetic Macular Edema (4SIGHT)

Sponsor: 4D Molecular Therapeutics

Who Can Participate

Inclusion Criteria

Individuals eligible to participate in the trial must meet the following inclusion criteria: General Inclusion Criteria
Signed informed consent before any protocol-specified assessment is performed
Ability and willingness to comply with the protocol-specified procedures (including IVT injection) and visits, in the Investigator's judgment
≥18 years of age at time of signing informed consent
Documented diagnosis of diabetes mellitus (Type 1 or Type 2)
WOCBP must agree to use highly effective contraception from the time of informed consent, through duration of trial participation
Agree to use a barrier method (e.g., condom) during intercourse for 3 months after Day 1 to prevent fluid transmission; sexually active males should not father a child or donate sperm during this period Ocular Inclusion Criteria
Macular thickening secondary to DME involving the center of the fovea (confirmed by the Reading Center) in the study eye
Study eye amenable to IVT injection identified
Presence of intraretinal fluid and/or subretinal fluid secondary to DME
Decreased visual acuity attributable primarily to DME, as determined by the Investigator
Demonstrated clinical response to aflibercept and functional stability in the study eye

Exclusion Criteria

Individuals who meet any of the following exclusion criteria will not be eligible to participate: Ocular Condition
Macular conditions other than DME
History or presence of moderate Proliferative Diabetic Retinopathy or worse
History of retinal detachment in the study eye
History or presence of active inflammation or infection in either eye
History or presence of low Intraocular Pressure
Uncontrolled glaucoma or intraocular hypertension Ocular Treatments/Interventions:
Any prior concomitant treatment for DME
History of prior significant ocular surgery or treatment
Any prior investigational drug, agent, device, or gene therapy

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Walnut Creek?

Yes, this clinical trial (NCT07867080) has an active research site in Walnut Creek, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Diabetic Macular Edema (DME) Treatment Options in Walnut Creek, CA

If you're searching for diabetic macular edema (dme) treatment options in Walnut Creek, CA, this clinical trial (NCT07867080) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Walnut Creek research site is actively enrolling participants for this phase 3 clinical trial. You'll receive care from experienced diabetic macular edema (dme) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all diabetic macular edema (dme) clinical trials near you to find additional studies recruiting in your area.

More Essential Tremor Trials in Walnut Creek, CA

See all essential tremor clinical trials recruiting in Walnut Creek — not just this study.

Browse Essential Tremor Trials in Walnut Creek →

Browse More Trials by Condition

Essential Tremor TrialsType 2 Diabetes TrialsErectile Dysfunction TrialsInterstitial Cystitis TrialsDiabetic Retinopathy TrialsMyalgic Encephalomyelitis TrialsAll Conditions →

Ready to Join in Walnut Creek?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Walnut Creek, CA